|
Federal
Register Notices > Notice
of Application >
Aldrich Chemical Company, Inc., DBA Isotec,
FR Doc E7-12976 [Federal Register: July 5, 2007 (Volume 72, Number 128)]
[Notices] [Page 36727-36728] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05jy07-108]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR),
this is notice that on May 18, 2007, Aldrich Chemical Company, Inc., DBA Isotec,
3858 Benner Road, Miamisburg, Ohio 45342-4304, made application by renewal to
the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic class of controlled substance listed in schedule I and
II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
N,N-Dimethylamphetamine (1480)
|
I
|
|
Aminorex (1585)
|
I
|
|
Gamma Hydroxybutyric Acid (2010)
|
I
|
|
Methaqualone (2565)
|
I
|
|
Ibogaine (7260)
|
I
|
|
Lysergic acid dethylamide (7315)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
N-Ethyl-1-phenylcyclohexylamine (7455)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Normorphine (9313)
|
I
|
|
Acetylmethadol (9601)
|
I
|
|
Alphacetylmethadol except levo-alphacetylmethadol (9603)
|
I
|
|
Normethadone (9635)
|
I
|
|
Norpipanone (9636)
|
I
|
|
3-Methylfentanyl (9813)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
1-Phenylcyclohexylamine (7460)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Phenylacetone (8501)
|
II
|
|
1-Piperidinocyclohexanecarbonitrile (8603)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Isomethadone (9226)
|
II
|
|
Meperidine (9230)
|
II
|
|
Meperidine intermediate-A (9232)
|
II
|
|
Merperidine intermediate-B (9233)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone intermediate (9254)
|
II
|
|
Dextropropoxyphene,bulk, (non-dosageforms)(9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Normorphine (9313)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture small quantities of the listed controlled
substances to produce isotope labeled standards for drug testing and analysis.
Any other such applicant and any person who is presently registered with
[[Page 36728]]
DEA to manufacture such a substance may file comments or objections to the
issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), Washington, D.C.
20537, or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
2401 Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed no
later than September 4, 2007.
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E7-12976 Filed 7-3-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
